| ||||
WASHINGTON (AP) -- Medicare officials are backing off a policy that pushed many doctors to use a $2,000 injectable drug for a potentially blinding eye disorder, over a similar treatment that costs about $50.
| News brought to you by: | |
 |  |
WASHINGTON (AP) -- Medicare officials are backing off a policy that pushed many doctors to use a $2,000 injectable drug for a potentially blinding eye disorder, over a similar treatment that costs about $50.
|
